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Cardiac-resynchronization therapy (CRT) improves the cardiac function of patients with
left ventricular (LV) dyssynchrony. Maintenance of the biventricular pacing rate is very
important in managing the hemodynamics in patients implanted with CRT devices.
A low biventricular pacing rate, for example, in cases with atrial ﬁbrillation or rapid
intrinsic atrioventricular (AV) conduction, decreases the beneﬁts of CRT. The LUMAX
HF-T 540 device series (BIOTRONIK, Berlin, Germany) has a LV-triggered pace algo-
rithm, which allows biventicular pacing rates to be maintained even during rapid
intrinsic rhythms caused by shortened AV conduction and/or premature ventricular
contraction (PVC) occurring in the right ventricle. We encountered a case of CRT device
implantation with a deﬁbrillator wherein this triggered pace algorithm caused a spike
on T-wave due to T-wave oversensing. By remote monitoring, we were also able to
determine that the T-wave oversensing was due to a PVC. The LUMAX 540 series allows
for changes in the sensing threshold and ﬁlter settings of the device, which facilitated
the elimination of T-wave oversensing in this case.
& 2012 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.1. Introduction
Cardiac resynchronization therapy (CRT) improves the
cardiac function of patients with left ventricular (LV)
systolic dysfunction and a wide QRS complex. Mainte-
nance of the biventricular pacing rate is very important in
managing patients implanted with CRT devices. A low
biventricular pacing rate defeats the purpose of selecting
this device because it decreases the hemodynamic bene-
ﬁts of CRT. The LUMAX 540 series has a LV-triggered pace
algorithm, which allows the maintenance of the biventi-
cular pacing rates even during rapid intrinsic rhythms
caused by shortened atrioventricular (AV) conductionrt Rhythm Society. Publish
(M. Fujimoto).and/or premature ventricular contraction (PVC) occurring
in the right ventricle. We report a case of implantation
of a CRT device with a diﬁbrillator (CRT-D) wherein this
triggered pace algorithm caused a spike on T wave due to
T-wave oversensing.2. Case report
A 67-year-old man was ﬁrst hospitalized with heart
failure and diagnosed with dilated cardiomyopathy 14
years ago. Thereafter, he was managed as an outpatient at
our hospital. The patient developed paroxysmal atrial
ﬁbrillation (AF) in February 2000. This AF had converted
to persistent AF in June 2003. Subsequently, he presented
with intermittent left bundle-branch block (LBBB) in
February 2008, and at that time, his brain natriuretic
peptide (BNP) level was 130 pg/ml. In January 2010, theed by Elsevier B.V. All rights reserved.
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shortness of breath due to complete LBBB along with a
gradual increase in BNP level. He was then admitted to
our hospital with worsening heart failure in June 2010,
qualifying as a New York Heart Association functional
class III patient. At admission, the patient had leg edema
and dyspnea. His blood pressure and heart rate were 131/
93 mmHg and 110 bpm, respectively. His laboratory data
was as follows: hemoglobin level of 8.7 g/ml, consistently
over a period of 5 years, indicating anemia and creatine
level of 1.2 mg/dl and a BNP level of 385 pg/ml, indicative
of mild renal insufﬁciency. His 12-lead electrocardiogram
showed AF with rapid ventricular rates and a QRS com-
plex duration of 154 ms. Echocardiography revealed a low
ejection fraction (EF) of 26%; LV end-diastolic diameter
(LVDd), 75 mm; LV end-systolic diameter (LVDs), 66 mm;
and LV dyssynchrony. The cardiothoracic ratio (CTR) was
67%, and plural effusion was observed on a chest radio-
graph at admission. After his condition stabilized with
optimal medications, he complained of exertional dys-
pnea. Therefore, we performed cardiopulmonary exercise
testing, which revealed a low anaerobic threshold (AT)
oxygen consumption level of 11.0 ml kg1 min1.
Treatment administered thereafter involved 2 approaches.
Because the patient had LV dyssynchrony with LBBB, we
planned to implant a biventricular pacing device. A CRT-D
was chosen despite the absence of syncope and non-sus-
tained ventricular tachycardia. The choice of the device was
based on the presence of ventricular tachycardia in conjunc-
tion with a low EF in this case and previous reports suggest-
ing the arrhythmogenic nature of biventricular pacing [1].
Before implantation, we performed catheter ablation to treat
the patient’s AF, which had the potential to prevent the
establishment of a sufﬁcient biventricular pacing rate and
could lead to the generation of inappropriate shocks. We also
believed that ablation therapy could boost the cardiac
performance by recovering sinus rhythm. At the time of the
operation, the left atrial dimension was 46mm. The outcome
of AF ablation was positive. The patient successfully recov-
ered sinus rhythm; his AT level increased to 12.0 ml
kg1 min1; and his BNP level decreased from 259 to
119 pg/ml. We then performed CRT-D implantation. The
CRT-D used was a Lumax 540 HF-T, and the shock leadFig. 1. Electrocardiogram after CRT-D implantatiowas a Linox S65, which is a true bipolar lead (BIOTRONIK,
Berlin, Germany). The CRT-D was programmed as follows:
the pacing mode was set at dual-chamber (DDD); basic rate,
60 bpm; AV delay, 150ms; VV delay, 0 ms; the upper
tracking rate, 130 ms; the right ventricular (RV) sensitivity,
0.4 mV; LV sensitivity, 1.6 mV. The RV amplitude was set at
7.9 mV, and LV amplitude, at 28mV. The RV pacing threshold
was maintained at 0.4 V, and LV pacing threshold, at 0.8 V.
Biventricular pacing yielded a narrow QRS complex at a
duration of 100ms.
No arrhythmias or major issues were detected at
monthly device checks and during remote home monitor-
ing for more than 2 months after device implantation.
However, we noticed a spike on the T wave in the 12-lead
electrocardiogram 3 months after CRT-D implantation
(Fig. 1). Device checks revealed T-wave oversensing and
a pacing spike on T wave caused by the LV-triggered pace
algorithm (Fig. 2). LV pacing was performed at the same
time as the T wave was sensed because this algorithm
misjudged the T wave as a PVC originating from the right
ventricle. At that time, the RV amplitude was set at
9.0 mV. After this algorithm was discontinued, the spike
on the T wave did not occur again. However, T-wave
oversensing continued to be observed. The CRT-D device
allows for changing the T-wave sensing threshold and
ﬁlter settings to eliminate oversensing. After changing the
sensing threshold, we conﬁrmed the ventricular sensing
threshold and set the ventricular sensing parameter to
2.0 mV. Thereafter, PVCs thought to represent T-wave
oversensing were not observed, as was also conﬁrmed
via remote home monitoring. Moreover, this alteration in
the sensing threshold did not affect the detection of
ventricular ﬁbrillation. We did not change the ‘‘RVs’’
mode of the LV-triggered algorithm because the patient
maintained sinus rhythm and had few PVCs (conﬁrmed
via remote home monitoring). During the follow-up
period, the CRT-D parameters, e.g., P wave, RV and LV
amplitudes, and thresholds, remained unchanged. After
the sensing threshold was changed, the biventricular
pacing rate was maintained more than 99% of the time.
His cardiac function improved: the CTR was 44%; the
LVDd/LVDs was 61/46 mm; and the EF was 47% at about 4
months after device implantation.n. The fourth beat is a spike on the T wave.
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Fig. 2. Telemetry ﬁndings by programmer. A: atrium, RV: right ventricle, LV: left ventricle, S: sense, P: pace. From the top: atrial event, right ventricular
event, left ventricular event, surface electrocardiogram, atrial intra-cardiac electrogram, right ventricular intra-cardiac electrogram, and left intra-cardiac
electrogram. The T wave after the third paced QRS complex was sensed by the RV lead, and the pacing spike triggering RV sense fell on the apex of the
T wave from the LV lead. The T wave after the fourth paced QRS complex was sensed by the RV lead; however, LV pacing was not performed because the
upper tracking rate was surpassed.
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It is obvious that CRT improves the prognosis of
patients with a low EF and LV dyssynchrony. Therefore,
retaining a biventricular pacing rate is important in these
patients [2–6]. However, patients with AF do not beneﬁt
from CRT to the same extent as those in sinus rhythm
[7–11]. This is mainly due to a low biventricular pacing
rate in AF cases. Methods employed to maintain a high
percentage of biventricular pacing rate include the phar-
maceutical rate-control approach of administering beta-
blockers or even performing AV nodal ablation. Several
CRT device algorithms have been developed to maintain
the biventricular pacing rate. The LV-triggered pace
algorithm, which is used in BIOTRONIK devices, is one
of them.
In our case, the LV-triggered pace algorithm had 2
modes: ‘‘RVs’’ and ‘‘RVsþRVEs’’. In the ‘‘RVs’’ mode, LV
pacing synchronizes with RV-sensed events. It aims to
maintain the CRT beneﬁts even if intrinsic AV conduction
shortens with an increase in sympathetic nerve activity.
In the ‘‘RVsþRVEs’’ mode, LV pacing synchronizes with
both RV-sensed events as well as PVCs of RV origin. This
algorithm is useful in minimizing the loss of a high
biventricular pacing rate. The LV-triggered pacing mode
applied in this case was ‘‘RVsþRVEs’’. The T-wave was
judged as a PVC because of T-wave oversensing. As a
result, LV pacing occurred at the same time as that of the
appearance of T waves. The spike on the T wave disap-
peared by changing the mode from ‘‘RVsþRVEs’’ to ‘‘RVs’’.
However, T-wave oversensing continued to be observed.
T-wave oversensing is one of the causes of inappropriateICD shocks [12–14]. LUMAX 540 series devices allow for
changes in several parameters to prevent T-wave over-
sensing. This series has both upper and lower threshold
segments of ventricular sensing after a constant blanking
and/or ventricular refractory period (Fig. 3). The nominal
upper threshold setting is 50%, and the lower one is 25% of
the QRS complex voltage. Each threshold can be selected
from among 3 levels. The upper threshold can be set at 50,
75, or 87.5%, while the lower threshold can be set at 12.5,
25, or 50% of the QRS complex voltage. The threshold can
also be set at a constant value of 2.0 mV. Besides allowing
for a selection of these thresholds, the device also permits
the programming of the minimum threshold. In addition,
the frequency of the high-cut and the low-cut ﬁlters can
be changed. In this case, we changed the upper and the
lower thresholds, ﬁxing both at 2.0 mV. The minimum
threshold of 0.8 mV was not changed. After the threshold
parameters were changed, the PVCs that were apparent
via remote home monitoring and turned out to be due to
T-wave oversensing disappeared. Some patients with a
low EF, who are considered candidates for CRT, have
frequent PVCs. The LV-triggered pace algorithm is thought
to be useful for synchronizing PVCs in such cases. If
T-wave oversensing is observed, as was in this case, it is
possible that the LV pacing occurs at the same time as the
T wave because T waves are misjudged as PVCs. There-
fore, programming of this algorithm must be done care-
fully. We ﬁrst observed T-wave oversensing about 2
months after device implantation. It might have occurred
due to an increase in the T-wave amplitude caused by
a reduction in the LV dimension with CRT. However,
T-wave oversensing could not have been predicted just
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Fig. 3. The setting of the ventricular sensing threshold to prevent T-wave oversensing. Vp: ventricular pacing, VRP: ventricular refractory period. The left
ﬁgure shows the upper and the lower thresholds after an intrinsic-QRS complex. The right ﬁgure shows the upper and the lower thresholds after a
ventricular-paced event by the CRT-D. The nominal upper threshold setting is 50%, and the lower one is 25% of the QRS complex voltage. The minimum
threshold (broken line) follows the lower threshold.
Fig. 4. Findings of remote home monitoring. (A) The CRT-D was implanted on July 9, 2010. PVCs that were suspected to be due to T-wave oversensing
had suddenly increased about 3 months after CRT-D implantation. A spike on the T wave was detected on a 12-lead electrocardiogram, and the
LV-triggered pace algorithm was discontinued at our outpatient clinic on September 21st. One week later, the upper ventricular sensing threshold
duration had increased from 350 ms to 400 ms. (B) Because of the continuation of T-wave oversensing, we set the ventricular sensing threshold to 2.0 mV
on December 27th. After changing the ventricular threshold, PVCs due to T-wave oversensing were not observed.
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position, RV-wave amplitude, and threshold did not
change after device implantation. However, T-wave over-
sensing can be recognized early by remote home mon-
itoring (Fig. 4), although a spike on T wave was observed
on the electrocardiogram at the clinic in this case.
4. Conclusions
In this case, a patient with an implanted CRT-D
exhibited a pacing spike on the T wave caused by the
device algorithm applied to maintain a biventricular
pacing rate. The reason for the spike on the T wave was
T-wave oversensing. It is possible to recognize T-wave
oversensing as PVCs and follow up patients exhibiting this
phenomenon by remote home monitoring. The LUMAX
540 series CRT-D produced by BIOTRONIK has various
ﬂexible device algorithms to prevent T-wave oversensing.
We could resolve the problem in this case by altering the
sensing threshold to prevent T-wave oversensing.
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